99 related articles for article (PubMed ID: 17593567)
1. From expert opinion to evidence-based: changes in the gold standard of primary brain tumour diagnosis.
Kros JM
J Pathol; 2007 Sep; 213(1):1-3. PubMed ID: 17593567
[TBL] [Abstract][Full Text] [Related]
2. [Neuropathology and molecular pathology of gliomas].
Janzer RC
Rev Med Suisse; 2009 Jul; 5(211):1501-4. PubMed ID: 19694359
[TBL] [Abstract][Full Text] [Related]
3. OMICS and brain tumour biomarkers.
Petrik V; Loosemore A; Howe FA; Bell BA; Papadopoulos MC
Br J Neurosurg; 2006 Oct; 20(5):275-80. PubMed ID: 17129872
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of class III beta-tubulin in primary brain tumours: variable expression in most tumour types limits utility as a differential diagnostic marker.
Laggner U; Pipp I; Budka H; Hainfellner JA; Preusser M
Histopathology; 2007 Jun; 50(7):949-52. PubMed ID: 17543088
[No Abstract] [Full Text] [Related]
5. Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology.
Gravendeel LA; Kouwenhoven MC; Gevaert O; de Rooi JJ; Stubbs AP; Duijm JE; Daemen A; Bleeker FE; Bralten LB; Kloosterhof NK; De Moor B; Eilers PH; van der Spek PJ; Kros JM; Sillevis Smitt PA; van den Bent MJ; French PJ
Cancer Res; 2009 Dec; 69(23):9065-72. PubMed ID: 19920198
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of CD68 and kallikrein 6 in human glioma.
Strojnik T; Kavalar R; Zajc I; Diamandis EP; Oikonomopoulou K; Lah TT
Anticancer Res; 2009 Aug; 29(8):3269-79. PubMed ID: 19661345
[TBL] [Abstract][Full Text] [Related]
7. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.
Hargrave D
Br J Neurosurg; 2009 Aug; 23(4):351-63. PubMed ID: 19637006
[TBL] [Abstract][Full Text] [Related]
8. The prognostic role of Ki-67 in childhood low-grade glioma.
Maurizi P; Ruggiero A; Attinà G; Cefalo MG; Arlotta A; Riccardi R
Pediatr Med Chir; 2008; 30(2):73-8. PubMed ID: 18581959
[TBL] [Abstract][Full Text] [Related]
9. Grading of gliomas: the road from eminence to evidence.
Kros JM
J Neuropathol Exp Neurol; 2011 Feb; 70(2):101-9. PubMed ID: 21343878
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic and prognostic values of 1p and 19q deletions in adult gliomas: critical review of the literature and implications in daily clinical practice].
Fontaine D; Vandenbos F; Lebrun C; Paquis V; Frenay M
Rev Neurol (Paris); 2008; 164(6-7):595-604. PubMed ID: 18565359
[TBL] [Abstract][Full Text] [Related]
11. Histomorphometry of brain tumours.
Nafe R; Schlote W
Neuropathol Appl Neurobiol; 2004 Aug; 30(4):315-28. PubMed ID: 15305977
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetic markers as predictors of response to chemotherapy in gliomas.
Idbaih A; Omuro A; Ducray F; Hoang-Xuan K
Curr Opin Oncol; 2007 Nov; 19(6):606-11. PubMed ID: 17906460
[TBL] [Abstract][Full Text] [Related]
13. Beyond grade: molecular pathology of malignant gliomas.
Sulman EP; Guerrero M; Aldape K
Semin Radiat Oncol; 2009 Jul; 19(3):142-9. PubMed ID: 19464628
[TBL] [Abstract][Full Text] [Related]
14. How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design.
Ransohoff DF
J Clin Epidemiol; 2007 Dec; 60(12):1205-19. PubMed ID: 17998073
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and predictive factors in colorectal cancer.
Zlobec I; Lugli A
J Clin Pathol; 2008 May; 61(5):561-9. PubMed ID: 18326017
[TBL] [Abstract][Full Text] [Related]
16. [Histological and molecular classification of gliomas].
Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and predictive factors in colorectal cancer.
Zlobec I; Lugli A
Postgrad Med J; 2008 Aug; 84(994):403-11. PubMed ID: 18832400
[TBL] [Abstract][Full Text] [Related]
18. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
19. Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists.
Sidiropoulos PI; Hatemi G; Song IH; Avouac J; Collantes E; Hamuryudan V; Herold M; Kvien TK; Mielants H; Mendoza JM; Olivieri I; Østergaard M; Schachna L; Sieper J; Boumpas DT; Dougados M
Rheumatology (Oxford); 2008 Mar; 47(3):355-61. PubMed ID: 18276738
[TBL] [Abstract][Full Text] [Related]
20. [Pediatric neuro-oncology].
Navajas-Gutiérrez A
Rev Neurol; 2006 Jul 16-31; 43(2):88-94. PubMed ID: 16838256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
